vancomycin

Vancomycin 是一种糖肽类抗生素，可以通过改变细胞膜的渗透性并选择性地抑制核糖核酸的合成以发挥抗菌活性。Vancomycin 可以用于治疗所有抗生素均无效的严重感染。

Vancomycin hydrochloride (Vancomycin HCl) 是Vancomycin 的盐酸盐，是一种支链三环糖基化肽，对大多数生物体具有杀菌活性，对肠球菌具有抑菌作用。

Ceftobiprole medocaril (BAL5788) 是 Ceftobiprole 的前药。Ceftobiprole 是一种广谱的头孢菌素，对耐甲氧西林金黄色葡萄球菌具有活性。

Ceftobiprole (Ro 63-9141) 是一种β-内酰胺类抗菌剂，通过与 PBP 结合，抑制细菌细胞壁的转肽化和形成，导致细胞裂解和死亡，从而显示出有效的杀菌活性，对甲氧西林耐受的金黄色葡萄球菌的MIC90值为 2 μg mL。

Vancomycin monohydrochloride is an amphoteric glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to peptidoglycan.

Norvancomycin hydrochloride (Desmethyl-vancomycin hydrochloride) 可用于葡萄球菌所致的心内膜炎、骨髓炎、肺炎、败血症或软组织感染。

Vancomycin-C13,D3 是一种由 13C 和 2H 标记的化合物。Vancomycin 是一种糖肽类抗生素，可以通过改变细胞膜的渗透性并选择性地抑制核糖核酸的合成以发挥抗菌活性。

Vancomycin-d12 TFA 是 Vancomycin TFA 的氘代化合物。Vancomycin TFA 的 CAS 号为 1404-90-6。Vancomycin 是一种抗生素，用于通过阻止细菌生长来治疗严重的细菌感染。它还改变细胞膜的渗透性并选择性地抑制核糖核酸的合成。

Tadalafil hydroxypiperidone is an impurity of Tadalafil -- a phosphodiesterase 5-inhibitor used for the treatment of erectile dysfunction.

N-Demethylvancomycin is a glycopeptide antibiotic that has been found inNocardia orientalis.1It is active against several strains ofS. aureusandS. epidermidisin vitroandin vivo.2Formulations containing N-demethylvancomycin have been used in the treatment of bacterial infections. 1.Boeck, L.D., Mertz, F.P., Wolter, R.K., et al.N-demethylvancomycin, a novel antibiotic produced by a strain of Nocardia orientalis. Taxonomy and fermentationJ. Antibiot. (Tokyo)37(5)446-453(1984) 2.Hunt, A.H., Marconi, G.G., Elzey, T.K., et al.A51568A: N-demethylvancomycinJ. Antibiot. (Tokyo)37(8)917-919(1984)

N-Demethylvancomycin，一种源自Nocardia orientalis的糖肽类抗生素，对多种金黄色葡萄球菌和表皮葡萄球菌菌株显示出抗菌活性，常被应用于感染相关研究。

Ridinilazole (SMT19969) 是一种新型的窄谱非吸收性抗生素。它显示出对艰难梭菌的有效抑制作用 (MIC90=0.125 mg L)，并且比甲硝唑 (MIC90 = 8 mg L) 或万古霉素 (MIC90 = 2 mg L) 更有效。

Tedizolid phosphate is a novel antibacterial prodrug. Tedizolid phosphate is a next-generation oxazolidinone with activity against both methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus spp. It also has effective activity a

Arcopilin A（compound Arcopilin A(1)）属于抗菌化合物，虽然对真菌病原体和革兰氏阳性菌的抑制力较弱，其对KB-3-1和L929细胞的IC50分别为8.9 μg mL和14 μg mL。此外，Arcopilin A能有效破坏金黄色葡萄球菌预先形成的生物膜，并显著增强庆大霉素(GM)和万古霉素(Vac)的活性，分别提高至115倍和31倍。

DNA Gyrase-IN-12 (Compound 6d) 作为一种DNA gyrase抑制剂，展示了针对金黄色葡萄球菌 (VISA) 和粪肠球菌的显著抗菌 (Antibacterial) 活性。其MIC值范围为0.031至0.0625 μg mL。

1-Amino-2,5-anhydro-1-deoxy-D-mannitol展现出对多种革兰氏阳性细菌的卓越抗菌效果，特别是对耐甲氧西林金黄色葡萄球菌（MRSA）和耐万古霉素肠球菌（VRE），显示了其潜力作为对抗抗药性细菌感染的有效方案。这一化合物在开发新型抗菌药物方面具有重要的应用前景，可能为临床上抗菌治疗提供新的策略。

Anti-MRSA agent 19（Compound 1）是一种有效抗金黄色葡萄球菌的抗生素。该化合物对40种CDC分离出的细菌株显示出活性（中位 MIC=4 μg mL），这些细菌株具有不同种类并携带多种耐药性因子，如万古霉素、氨基糖苷类 四环素及恶唑烷酮。

V-161是一种口服有效的Na+-V-ATPase抑制剂，IC50值为144 nM。在碱性环境中，V-161能够抑制Enterococcus hirae和耐万古霉素Enterococcus faecium (VRE)，其MIC均为4 µg mL。此外，V-161可以抑制VRE在小鼠小肠中的定殖。

KKL-40 是一种小分子抑制剂，专门针对反式转录过程，能够有效抑制甲氧西林敏感和耐药的金黄色葡萄球菌 (S. aureus)，以及包括耐万古霉素的屎肠球菌、枯草芽孢杆菌和化脓性链球菌在内的其他革兰氏阳性病原体。KKL-40 与人类抗菌肽 LL-37 协同作用可抑制金黄色葡萄球菌，但与达托霉素、卡那霉素或红霉素等其他抗生素之间没有协同效应。反式转录是一种极端的重新编码形式，KKL-40 能抑制该过程，同时对 HeLa 细胞无毒。

Adicillin is a penicillin antibiotic that works against vancomycin-resistant enterococci.

Lytixar is a Synthetic Antimicrobial Peptide, it shows activity against Daptomycin-Nonsusceptible, Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, and Linezolid-Nonsusceptible Staphylococcus aureus. LTX-109 demonstrated a MIC range o

ABT-719 is a 2-pyridinone antimicrobial agent that is more effective against Enterococcus faecalis strains than ciprofloxacin and vancomycin, which showed resistance to ciprofloxacin and vancomycin covering a range of MIC.

Lipid II binder 5107930 is a lipid II binder which causes specific upregulation of the vancomycin-resistance associated gene vraX, which is implicated in the cell wall stress stimulon that confers glycopeptide resistance.

(-)-Viriditoxin is a mycotoxin originally isolated from A. viridinutans that has antibacterial and antiproliferative activity. It is active against methicillin-sensitive and -resistant S. aureus (MSSA and MRSA, respectively), tetracycline-sensitive and -resistant Staphylococcus, vancomycin-sensitive and -resistant Enterococcus, and penicillin-sensitive and -resistant S. pneumoniae (MICs = 2-32 μg/ml). (-)-Viriditoxin is also active against fish pathogens, including S. iniae and S. parauberis (MICs = 0.16-0.21 μg/ml). It inhibits polymerization and the GTPase activity of E. coli FtsZ, a tubulin-like GTPase involved in bacterial cell division (IC50s = 8.2 and 7 μg/ml, respectively). (-)-Viriditoxin inhibits proliferation of human DU145, LNCaP, and PC3 prostate cancer cells (IC50s = 5.36, 0.63, and 7.6 μM, respectively) . It is also toxic to mice (LD50 = 2.8 mg/kg, i.p.).